Health Canada recently approved lecanemab (brand name Leqembi®) to treat people with mild cognitive impairment or mild ...

Revenue for Q3 2025 was $17.11 million, an increase of 38% from $12.41 million in Q3 2024, marking a new all-time high and reflecting significant growth across all core divisions. For the nine months ...

Cosmos Health Inc. ('Cosmos Health' or the 'Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare ...

Elite Pharmaceuticals, Inc. ( OTCQB:ELTP) Q2 2026 Earnings Call November 17, 2025 11:30 AM EST Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Second Quarter of Fiscal ...

Cancer patients can get all of their care in a single Ontario location that is well known, centrally located and easily ...

Everywhere you look, the United States is at war– at home, through military occupation of cities, institutional violence, and ...

Detailed price information for National Vision Holdings Inc (EYE-Q) from The Globe and Mail including charting and trades.

The Spinach (R) brand ended Q3 2025 as the second most popular brand in Canada, holding a 4.5% total market share. Spinach (R) flower ranked as the fourth most popular flower brand with 4.9% market ...

Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in ...

THOUSAND OAKS, Calif., Nov. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2025.

It's always nice to have a movie that people talk about, and it feels like Yorgos Lanthimos is a filmmaker who sort of sets ...

The act of bringing another person into the world comes with a whole host of things you might not have anticipated, from a ...